Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP972046priorityCriticalpatent/ECSP972046A/en
Publication of ECSP972046ApublicationCriticalpatent/ECSP972046A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
La presente invención se relaciona con una fórmula posológica y dosis unitaria de la misma, de clorhidrato de venlafaxina, un agente antidepresivo, de liberación prolongada sobre 24 horas, que ofrece un control de las concentraciones plasmáticas mejor que el de las fórmulas convencionales en tabletas que deberán administrarse dos o más veces al día, y que también se asocia con una incidencia más baja de náuseas y vómitos que las tabletas convencionales.The present invention relates to a dosage formula and unit dose thereof, of venlafaxine hydrochloride, an antidepressant agent, prolonged-release over 24 hours, which offers better control of plasma concentrations than conventional tablet formulations than They should be administered two or more times a day, and that is also associated with a lower incidence of nausea and vomiting than conventional tablets.
ECSP9720461997-03-041997-03-04
PROLONGED RELEASE FORMULA
ECSP972046A
(en)